Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-01-14

Clinical Trial Update: Sevelamer Hydrochloride and Femoral and Carotid Intima Media Thickness Progression in End Stage Renal Disease [NA]

View source ↗

Summary

Clinical trial update examining the effect of Sevelamer Hydrochloride on progression of femoral and carotid intima-media thickness in patients with end-stage re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Renagel (sevelamer)

Snippet

Sponsor: Tel-Aviv Sourasky Medical Center | Conditions: End Stage Renal Disease, Hemodialysis | NA | Status: COMPLETED